Literature DB >> 28552146

Epidemiology of cavernous malformations.

Hannah E Goldstein1, Robert A Solomon2.   

Abstract

Cavernous malformations, accounting for approximately 5-15% of all vascular abnormalities in the central nervous system, are angiographically occult lesions which most often present with seizures, rather than acute hemorrhage. Widely variable across populations, the incidence of cavernous malformations has been reported to be 0.15-0.56 per 100 000 persons per year, with an annual hemorrhage rate of 0.6-11% per patient-year. Seen in 0.17-0.9% of the population, up to one-half are familial, and at least three gene loci have been associated with a familial form, more common among Hispanic Americans. Most cavernous malformations are supratentorial, with 10-23% in the posterior fossa, and approximately 5% found in the spine.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  cavernous malformation; epidemiology; incidence; population; prevalence

Mesh:

Year:  2017        PMID: 28552146     DOI: 10.1016/B978-0-444-63640-9.00023-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  8 in total

Review 1.  Presentation and management of nervous system cavernous malformations in children: A systematic review and case report.

Authors:  Uma V Mahajan; Mohit Patel; Jonathan Pace; Brian D Rothstein
Journal:  Brain Circ       Date:  2022-09-21

2.  Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.

Authors:  Wenqing Li; Virginia Tran; Iftach Shaked; Belinda Xue; Thomas Moore; Rhonda Lightle; David Kleinfeld; Issam A Awad; Mark H Ginsberg
Journal:  Elife       Date:  2021-05-20       Impact factor: 8.140

3.  Cribra orbitalia is a vascular phenomenon unrelated to marrow hyperplasia or anemia: Paradigm shift for cribra orbitalia.

Authors:  Bruce M Rothschild; Matthew J Zdilla; Lyman M Jellema; H Wayne Lambert
Journal:  Anat Rec (Hoboken)       Date:  2020-11-09       Impact factor: 2.227

4.  Intrasellar cavernous hemangiomas: A case report with a comprehensive review of the literature.

Authors:  Sultan Al-Saiari; Khalid Al-Orabi; Ahmed Farag; Zaina Brinji; Azza Azzouz; Tahira Mohammed; Deepa Mushtaq; Waeel Hamouda
Journal:  Surg Neurol Int       Date:  2021-02-17

5.  Levetiracetam-Induced Psychosis in the Setting of Intracranial Cavernomas.

Authors:  Daniel Majarwitz; Mariam Dvalishvili; Irene Pastis
Journal:  Case Rep Psychiatry       Date:  2022-03-21

Review 6.  Variable histopathology features of neuronal dyslamination in the cerebral neocortex adjacent to epilepsy-associated vascular malformations suggest complex pathogenesis of focal cortical dysplasia ILAE type IIIc.

Authors:  Hajime Miyata; Haruka Kuwashige; Tomokatsu Hori; Yuichi Kubota; Tom Pieper; Roland Coras; Ingmar Blümcke; Yasuji Yoshida
Journal:  Brain Pathol       Date:  2022-01-09       Impact factor: 7.611

7.  Transnasal endoscopic removal of a retrochiasmatic cavernoma: A case report and review of literature.

Authors:  Cesare Zoia; Daniele Bongetta; Gianluigi Dorelli; Sabino Luzzi; Mattia Del Maestro; Renato J Galzio
Journal:  Surg Neurol Int       Date:  2019-05-10

8.  Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Authors:  Anthony C Y Yau; Maria Ascencion Globisch; Favour Chinyere Onyeogaziri; Lei L Conze; Ross Smith; Suvi Jauhiainen; Monica Corada; Fabrizio Orsenigo; Hua Huang; Melanie Herre; Anna-Karin Olsson; Matteo Malinverno; Veronica Sundell; Behnam Rezai Jahromi; Mika Niemelä; Aki Laakso; Cecilia Garlanda; Alberto Mantovani; Maria Grazia Lampugnani; Elisabetta Dejana; Peetra U Magnusson
Journal:  Cell Mol Life Sci       Date:  2022-03-25       Impact factor: 9.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.